HEPARIN SODIUM AND DEXTROSE

HEPARIN SODIUM AND DEXTROSE was reported 723 times

HEPARIN SODIUM AND DEXTROSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 42 0.2121
1 ANTACID THERAPY 27 0.2077
2 APPENDICOLITH 77 0.1990
3 ANALGESIC THERAPY 44 0.1371
4 DRUG THERAPY 44 0.1298
5 ANTICOAGULANT THERAPY 27 0.0951
6 CONGENITAL HIATUS HERNIA 20 0.0877
7 FRACTION OF INSPIRED OXYGEN 1 0.0833
8 MALIGNANT MELANOMA STAGE 0 17 0.0813
9 BACTEROIDES INFECTION 19 0.0728
10 CONJUNCTIVAL RETRACTION 1 0.0625
11 SPONTANEOUS HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME 1 0.0588
12 BRONCHIAL ASPIRATION PROCEDURE 1 0.0556
13 ADRENAL THROMBOSIS 1 0.0455
14 CEREBRAL MICROEMBOLISM 1 0.0455
15 THROMBOSIS PROPHYLAXIS 2 0.0339
16 HEPARIN RESISTANCE 4 0.0328
17 PERIPARTUM HAEMORRHAGE 1 0.0244
18 THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME 1 0.0238
19 BLOOD PHOSPHORUS INCREASED 65 0.0238
20 HYPERPHOSPHATAEMIA 51 0.0237
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 19 0.0205
22 PROTEIN C DECREASED 2 0.0194
23 BULLOUS HAEMORRHAGIC DERMATOSIS 4 0.0190
24 CONJUNCTIVAL BLEB 1 0.0185
25 ANTI FACTOR X ACTIVITY INCREASED 1 0.0185
26 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 7 0.0167
27 SPINAL SUBARACHNOID HAEMORRHAGE 1 0.0167
28 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0159
29 SPONTANEOUS SPLENIC RUPTURE 1 0.0152
30 TOTAL LUNG CAPACITY DECREASED 24 0.0150
31 ORAL MUCOSA HAEMATOMA 1 0.0137
32 PROTEIN S DECREASED 2 0.0135
33 SPINAL CORD ISCHAEMIA 2 0.0132
34 SPINAL EPIDURAL HAEMORRHAGE 1 0.0123
35 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 1 0.0119
36 HAEMODIALYSIS COMPLICATION 2 0.0118
37 UMBILICAL DISCHARGE 1 0.0116
38 ANTITHROMBIN III DEFICIENCY 1 0.0112
39 HEPARIN-INDUCED THROMBOCYTOPENIA 54 0.0109
40 IRON DEFICIENCY 47 0.0104
41 BLOOD URIC ACID INCREASED 59 0.0102
42 REFRACTORINESS TO PLATELET TRANSFUSION 1 0.0092
43 FASCIOTOMY 1 0.0089
44 MICROEMBOLISM 1 0.0088
45 TARGET SKIN LESION 1 0.0088
46 LUNG OPACITY 23 0.0087
47 DYSTROPHIC CALCIFICATION 1 0.0087
48 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 43 0.0085
49 APPENDICITIS 77 0.0082
50 MYASTHENIA GRAVIS 66 0.0082
51 AORTIC STENOSIS 28 0.0080
52 HYPOPHOSPHATAEMIA 59 0.0080
53 SPINAL SUBDURAL HAEMATOMA 1 0.0077
54 ANTITHROMBIN III DECREASED 2 0.0073
55 HAEMATOMA EVACUATION 2 0.0071
56 VENTRICULAR FIBRILLATION 78 0.0070
57 LUDWIG ANGINA 1 0.0069
58 COAGULATION FACTOR VIII LEVEL INCREASED 1 0.0068
59 SPINAL EPIDURAL HAEMATOMA 4 0.0068
60 PERITONEAL HAEMATOMA 1 0.0067
61 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
62 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 5 0.0065
63 ANTICOAGULANT-RELATED NEPHROPATHY 1 0.0063
64 LARYNGEAL INJURY 1 0.0058
65 PLEURITIC PAIN 16 0.0058
66 INTRACARDIAC MASS 1 0.0056
67 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 1 0.0053
68 CARDIOGENIC SHOCK 75 0.0052
69 TONGUE HAEMATOMA 1 0.0051
70 RESPIRATORY SYMPTOM 14 0.0049
71 ADRENOMEGALY 1 0.0048
72 SPINAL CORD HAEMATOMA 1 0.0047
73 TROPONIN INCREASED 33 0.0043
74 EXTRAVASATION BLOOD 1 0.0042
75 VASCULAR PSEUDOANEURYSM 7 0.0040
76 BUDD-CHIARI SYNDROME 1 0.0040
77 MICROSCOPIC POLYANGIITIS 1 0.0039
78 THORACIC CAVITY DRAINAGE 1 0.0037
79 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
80 CATHETER SITE THROMBOSIS 1 0.0036
81 BLOOD CALCIUM INCREASED 32 0.0036
82 TRAUMATIC HAEMOTHORAX 1 0.0036
83 CEREBELLAR HAEMATOMA 1 0.0036
84 PUTAMEN HAEMORRHAGE 1 0.0035
85 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
86 CORONARY ARTERY EMBOLISM 1 0.0034
87 HAEMATOMA MUSCLE 4 0.0033
88 COAGULATION TIME ABNORMAL 1 0.0033
89 BREATH SOUNDS ABNORMAL 16 0.0032
90 BRONCHIAL HAEMORRHAGE 1 0.0032
91 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 54 0.0031
92 THYROXINE FREE INCREASED 2 0.0031
93 BACTERIAL INFECTION 57 0.0031
94 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84 0.0030
95 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
96 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
97 HYPERLIPIDAEMIA 34 0.0028
98 RETROPERITONEAL HAEMORRHAGE 7 0.0028
99 CEREBRAL MASS EFFECT 1 0.0028
100 SPINAL CORD OEDEMA 1 0.0027
101 ASCITES 78 0.0027
102 VASCULAR GRAFT OCCLUSION 1 0.0026
103 OESOPHAGEAL INJURY 1 0.0026
104 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
105 FACTOR V LEIDEN MUTATION 1 0.0025
106 HAEMOPERITONEUM 2 0.0025
107 MANUFACTURING MATERIALS ISSUE 1 0.0025
108 NEURALGIA 60 0.0025
109 RED BLOOD CELL TRANSFUSION 1 0.0024
110 BLOOD TEST ABNORMAL 34 0.0024
111 ULCER 38 0.0024
112 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
113 COMPARTMENT SYNDROME 6 0.0023
114 PELVIC HAEMATOMA 1 0.0023
115 AIR EMBOLISM 1 0.0021
116 HEPATIC HAEMATOMA 1 0.0021
117 ARTERIAL THROMBOSIS 4 0.0021
118 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
119 ABDOMINAL WALL HAEMATOMA 4 0.0020
120 ARTERIOVENOUS FISTULA 1 0.0020
121 HYPOFIBRINOGENAEMIA 2 0.0020
122 GOUT 36 0.0020
123 END STAGE RENAL DISEASE 36 0.0020
124 VASCULAR STENT THROMBOSIS 4 0.0020
125 PROCEDURAL SITE REACTION 1 0.0019
126 SPLENIC RUPTURE 3 0.0018
127 RETROPERITONEAL HAEMATOMA 4 0.0018
128 ADRENAL HAEMORRHAGE 1 0.0018
129 TUMOUR RUPTURE 1 0.0018
130 ASPIRATION 19 0.0017
131 HAEMOTHORAX 5 0.0017
132 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
133 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
134 HYPERCHOLESTEROLAEMIA 16 0.0017
135 CEREBRAL ARTERY EMBOLISM 2 0.0016
136 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
137 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
138 FULL BLOOD COUNT ABNORMAL 16 0.0015
139 HYPONATRAEMIA 85 0.0015
140 MICTURITION URGENCY 17 0.0015
141 POSTPARTUM HAEMORRHAGE 2 0.0015
142 BREAST DISORDER 3 0.0015
143 HAND DERMATITIS 1 0.0014
144 CHYLOTHORAX 1 0.0014
145 SYSTEMIC SCLERODERMA 1 0.0014
146 LIP EROSION 1 0.0014
147 RESPIRATORY TRACT OEDEMA 1 0.0013
148 SPONTANEOUS HAEMATOMA 1 0.0013
149 COAGULATION TIME PROLONGED 2 0.0013
150 LABORATORY TEST INTERFERENCE 1 0.0013
151 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
152 GOUTY ARTHRITIS 1 0.0013
153 PENILE HAEMORRHAGE 1 0.0012
154 THROMBOSIS IN DEVICE 4 0.0012
155 RALES 7 0.0012
156 BLOOD CHOLESTEROL INCREASED 56 0.0012
157 MEAN PLATELET VOLUME DECREASED 1 0.0012
158 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
159 MUCOSAL EROSION 1 0.0011
160 IRON DEFICIENCY ANAEMIA 10 0.0011
161 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
162 ELECTRIC SHOCK SENSATION 3 0.0011
163 BRONCHIECTASIS 7 0.0010
164 HEMIANOPIA 1 0.0010
165 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
166 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
167 DEMYELINATING POLYNEUROPATHY 1 0.0010
168 PERICARDIAL HAEMORRHAGE 2 0.0009
169 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
170 LIVER FUNCTION TEST INCREASED 19 0.0009
171 BLOOD FIBRINOGEN DECREASED 1 0.0009
172 THROMBOSIS 70 0.0009
173 AORTIC THROMBOSIS 1 0.0009
174 SHOCK HAEMORRHAGIC 7 0.0009
175 HYPERTENSIVE EMERGENCY 1 0.0008
176 CARDIAC TAMPONADE 4 0.0008
177 DRY MOUTH 68 0.0008
178 SLEEP DISORDER 59 0.0008
179 PRODUCT PACKAGING CONFUSION 2 0.0008
180 MALIGNANT MELANOMA IN SITU 1 0.0008
181 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
182 DIABETES MELLITUS 61 0.0008
183 PULMONARY EMBOLISM 76 0.0008
184 JOINT INJURY 17 0.0008
185 SUBCUTANEOUS HAEMATOMA 1 0.0008
186 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
187 FOETAL DEATH 4 0.0008
188 TRANSAMINASES INCREASED 17 0.0008
189 EXTRADURAL HAEMATOMA 1 0.0008
190 SEPSIS 84 0.0008
191 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
192 SPUTUM DISCOLOURED 7 0.0007
193 ABDOMINAL DISTENSION 77 0.0007
194 RECURRENT CANCER 3 0.0007
195 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
196 CARDIOVERSION 1 0.0007
197 PERIPHERAL ARTERY OCCLUSION 1 0.0007
198 HAEMORRHAGE IN PREGNANCY 1 0.0007
199 INTENTIONAL PRODUCT MISUSE 58 0.0007
200 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
201 ORAL MUCOSAL ERUPTION 1 0.0007
202 STOMA SITE HAEMORRHAGE 1 0.0006
203 BRAIN DEATH 2 0.0006
204 PRODUCT DEPOSIT 1 0.0006
205 SWELLING 60 0.0006
206 INHIBITORY DRUG INTERACTION 1 0.0006
207 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
208 TUMOUR MARKER INCREASED 3 0.0006
209 VULVOVAGINAL PAIN 3 0.0006
210 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
211 RESUSCITATION 1 0.0006
212 ANTIBODY TEST POSITIVE 1 0.0006
213 EMBOLISM 5 0.0006
214 VENA CAVA THROMBOSIS 1 0.0006
215 DRUG INTOLERANCE 58 0.0006
216 CORONARY ARTERY DISEASE 18 0.0006
217 CARDIOVASCULAR DISORDER 15 0.0006
218 SKIN NECROSIS 3 0.0006
219 RECALLED PRODUCT 1 0.0006
220 SPLENIC INFARCTION 1 0.0006
221 JUGULAR VEIN THROMBOSIS 1 0.0006
222 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
223 PNEUMONIA KLEBSIELLA 1 0.0005
224 HAEMATOMA 14 0.0005
225 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
226 ACCIDENTAL DEATH 1 0.0005
227 HAEMOPTYSIS 15 0.0005
228 ADRENAL DISORDER 1 0.0005
229 PROCEDURAL HAEMORRHAGE 2 0.0005
230 BICYTOPENIA 1 0.0005
231 BLOOD CREATININE INCREASED 33 0.0005
232 QUADRIPLEGIA 1 0.0005
233 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
234 PULMONARY MASS 7 0.0005
235 LYMPHOCYTOSIS 1 0.0005
236 PLEURAL EFFUSION 28 0.0005
237 RENAL TUBULAR ACIDOSIS 1 0.0005
238 SUSPECTED OFF LABEL USE 2 0.0004
239 METASTASES TO MENINGES 1 0.0004
240 WEIGHT ABNORMAL 1 0.0004
241 DIABETES INSIPIDUS 1 0.0004
242 DERMATITIS BULLOUS 3 0.0004
243 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
244 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
245 FAECES SOFT 3 0.0004
246 GLOMERULONEPHRITIS 1 0.0004
247 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
248 CATHETER SITE HAEMORRHAGE 1 0.0004
249 ANAEMIA 72 0.0004
250 GINGIVAL PAIN 3 0.0004
251 MUSCULOSKELETAL STIFFNESS 33 0.0004
252 ABDOMINAL MASS 1 0.0004
253 SOMNOLENCE 75 0.0004
254 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
255 HYDROCEPHALUS 2 0.0004
256 APPLICATION SITE HAEMORRHAGE 1 0.0004
257 SUBDURAL HAEMORRHAGE 1 0.0004
258 HYPERAESTHESIA 3 0.0004
259 PULMONARY FIBROSIS 7 0.0004
260 VITREOUS HAEMORRHAGE 1 0.0004
261 INTRACRANIAL PRESSURE INCREASED 2 0.0004
262 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
263 BLOOD MAGNESIUM DECREASED 3 0.0003
264 PARAPLEGIA 1 0.0003
265 CONSTIPATION 75 0.0003
266 ABDOMINAL PAIN 79 0.0003
267 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
268 BRAIN HERNIATION 1 0.0003
269 GANGRENE 2 0.0003
270 BONE MARROW DISORDER 1 0.0003
271 LIVER DISORDER 14 0.0003
272 STEVENS-JOHNSON SYNDROME 7 0.0003
273 PORTAL VEIN THROMBOSIS 1 0.0003
274 CEREBRAL HAEMORRHAGE 11 0.0003
275 LISTLESS 1 0.0003
276 DRY THROAT 3 0.0003
277 ECCHYMOSIS 2 0.0003
278 TRANSFUSION 3 0.0003
279 THROMBOPHLEBITIS 1 0.0003
280 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
281 SEASONAL ALLERGY 4 0.0003
282 FIBRIN D DIMER INCREASED 1 0.0003
283 PYODERMA GANGRENOSUM 1 0.0003
284 CAROTID ARTERY OCCLUSION 1 0.0003
285 WOUND HAEMORRHAGE 1 0.0003
286 CARDIAC DYSFUNCTION 1 0.0003
287 LUNG DISORDER 13 0.0003
288 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
289 OEDEMA PERIPHERAL 32 0.0003
290 OESOPHAGEAL ULCER 1 0.0003
291 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
292 POST PROCEDURAL HAEMORRHAGE 3 0.0003
293 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
294 EPIGASTRIC DISCOMFORT 1 0.0003
295 PULMONARY HAEMORRHAGE 2 0.0003
296 VENOUS THROMBOSIS 1 0.0003
297 BLOOD IRON DECREASED 3 0.0003
298 PATENT DUCTUS ARTERIOSUS 1 0.0003
299 CONDITION AGGRAVATED 76 0.0002
300 MUSCLE HAEMORRHAGE 1 0.0002
301 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
302 EXTRAVASATION 1 0.0002
303 LEG AMPUTATION 1 0.0002
304 DRUG INEFFECTIVE 319 0.0002
305 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
306 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
307 POOR PERIPHERAL CIRCULATION 1 0.0002
308 UTERINE HAEMORRHAGE 1 0.0002
309 HAEMORRHAGIC ANAEMIA 1 0.0002
310 DYSMENORRHOEA 3 0.0002
311 BLOOD CREATINE INCREASED 1 0.0002
312 ISCHAEMIA 1 0.0002
313 SUBDURAL HAEMATOMA 3 0.0002
314 HYPOVOLAEMIC SHOCK 1 0.0002
315 RASH VESICULAR 1 0.0002
316 HYPOXIA 7 0.0002
317 KLEBSIELLA INFECTION 1 0.0002
318 VARICOSE VEIN 1 0.0002
319 PETECHIAE 2 0.0002
320 GASTROINTESTINAL DISORDER 17 0.0002
321 PREMATURE DELIVERY 3 0.0002
322 HAEMORRHAGE 19 0.0002
323 COAGULOPATHY 3 0.0002
324 HYPERTENSION 38 0.0002
325 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
326 PREMATURE LABOUR 1 0.0002
327 INTERNAL HAEMORRHAGE 2 0.0002
328 STRESS CARDIOMYOPATHY 1 0.0002
329 HYPERKALAEMIA 6 0.0002
330 ENERGY INCREASED 1 0.0002
331 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
332 ASTHMA 19 0.0002
333 PROTHROMBIN TIME PROLONGED 1 0.0002
334 ADRENAL INSUFFICIENCY 2 0.0002
335 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
336 VOMITING 75 0.0002
337 SKIN FISSURES 3 0.0002
338 POLYP 1 0.0002
339 PRODUCT PREPARATION ISSUE 1 0.0002
340 MENINGITIS 1 0.0001
341 WRONG PRODUCT ADMINISTERED 1 0.0001
342 RIGHT VENTRICULAR FAILURE 1 0.0001
343 DUODENAL ULCER 1 0.0001
344 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
345 MOUTH HAEMORRHAGE 1 0.0001
346 HAEMOGLOBIN DECREASED 14 0.0001
347 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
348 HAEMORRHAGE INTRACRANIAL 2 0.0001
349 SNEEZING 3 0.0001
350 EPISTAXIS 10 0.0001
351 HAEMODYNAMIC INSTABILITY 1 0.0001
352 PROCEDURAL COMPLICATION 1 0.0001
353 HAEMOLYSIS 1 0.0001
354 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
355 LOW BIRTH WEIGHT BABY 1 0.0001
356 HEMIPLEGIA 1 0.0001
357 PNEUMONIA ASPIRATION 3 0.0001
358 BLOOD UREA INCREASED 2 0.0001
359 FACIAL PARALYSIS 1 0.0001
360 HEPATITIS 3 0.0001
361 HAEMATURIA 4 0.0001
362 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
363 PURPURA 1 0.0001
364 EXPOSURE DURING PREGNANCY 7 0.0001
365 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
366 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
367 PULMONARY OEDEMA 5 0.0001
368 HAEMARTHROSIS 1 0.0001
369 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
370 LEUKOCYTOSIS 2 0.0001
371 RETINAL DETACHMENT 1 0.0001
372 UROSEPSIS 1 0.0001
373 ERYTHEMA MULTIFORME 1 0.0001
374 BLISTER 6 0.0001
375 ABORTION INDUCED 1 0.0001
376 GASTRIC ULCER 2 0.0001
377 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
378 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
379 ACUTE RESPIRATORY FAILURE 2 0.0001
380 TREMOR 17 0.0001
381 HOSPICE CARE 1 0.0001
382 POOR QUALITY DEVICE USED 1 0.0001
383 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
384 THERAPEUTIC RESPONSE DECREASED 6 0.0001
385 DYSPNOEA 56 0.0001
386 SUBARACHNOID HAEMORRHAGE 1 0.0001
387 NAUSEA 77 0.0001
388 NERVOUS SYSTEM DISORDER 3 0.0001
389 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
390 SUDDEN DEATH 1 0.0001
391 PNEUMONIA 30 0.0001
392 DEEP VEIN THROMBOSIS 6 0.0001
393 FAECES DISCOLOURED 2 0.0001
394 MELAENA 2 0.0001
395 BLOOD PRESSURE DECREASED 6 0.0001
396 RASH MACULO-PAPULAR 2 0.0001
397 HYPERTENSIVE CRISIS 1 0.0001
398 HEPATOTOXICITY 2 0.0001
399 THROMBOCYTOPENIA 10 0.0001
400 REBOUND EFFECT 1 0.0001
401 OFF LABEL USE 77 0.0001
402 SHOCK 2 0.0001
403 PERICARDIAL EFFUSION 2 0.0001
404 CAESAREAN SECTION 1 0.0001
405 VASCULITIS 1 0.0001
406 HEART RATE DECREASED 3 0.0001
407 WHEEZING 5 0.0001
408 BACTERAEMIA 1 0.0001
409 BURSITIS 1 0.0001
410 CEREBRAL INFARCTION 2 0.0001
411 RESPIRATORY DEPRESSION 1 0.0001
412 LIVER INJURY 2 0.0001
413 ENCEPHALOPATHY 2 0.0001
414 BRAIN OEDEMA 1 0.0001
415 DRUG RESISTANCE 2 0.0001
416 GENITAL HAEMORRHAGE 1 0.0001
417 INJECTION SITE INDURATION 1 0.0001
418 DEVICE OCCLUSION 1 0.0001
419 PARALYSIS 1 0.0001
420 HYPOTENSION 14 0.0001
421 CARDIOMYOPATHY 1 0.0001
422 SKIN HAEMORRHAGE 1 0.0001
423 ASTHENIA 25 0.0001
424 PREMATURE BABY 2 0.0001
425 APHASIA 2 0.0001
426 DEVICE RELATED INFECTION 1 0.0001
427 PYREXIA 22 0.0001
428 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
429 PNEUMOTHORAX 1 0.0001
430 VENTRICULAR TACHYCARDIA 1 0.0001
431 CYTOMEGALOVIRUS INFECTION 1 0.0001
432 CIRCULATORY COLLAPSE 1 0.0001
433 PRODUCT DOSE OMISSION ISSUE 17 0.0001
434 ECZEMA 3 0.0001
435 SYRINGE ISSUE 1 0.0001
436 LYMPHOCYTE COUNT DECREASED 1 0.0001
437 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
438 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
439 ISCHAEMIC STROKE 1 0.0001
440 HAEMATOCHEZIA 3 0.0001
441 CONJUNCTIVITIS 1 0.0001
442 HEPATIC FUNCTION ABNORMAL 2 0.0001
443 HYPOCALCAEMIA 1 0.0001
444 ACUTE KIDNEY INJURY 8 0.0001
445 POST PROCEDURAL COMPLICATION 1 0.0001
446 INJECTION SITE HAEMORRHAGE 4 0.0001
447 ABORTION SPONTANEOUS 2 0.0000
448 CYTOKINE RELEASE SYNDROME 1 0.0000
449 PLATELET COUNT DECREASED 5 0.0000
450 VAGINAL HAEMORRHAGE 2 0.0000
451 SEPTIC SHOCK 2 0.0000
452 PRODUCT DISPENSING ERROR 1 0.0000
453 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
454 ANGIOEDEMA 2 0.0000
455 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
456 TACHYCARDIA 4 0.0000
457 DEATH 38 0.0000
458 MENTAL IMPAIRMENT 1 0.0000
459 RESPIRATORY FAILURE 3 0.0000
460 FIBROMYALGIA 1 0.0000
461 PRESYNCOPE 1 0.0000
462 LEUKOPENIA 2 0.0000
463 HAEMATEMESIS 1 0.0000
464 PAIN 24 0.0000
465 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
466 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
467 INFLAMMATION 2 0.0000
468 SKIN ULCER 1 0.0000
469 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
470 RASH PRURITIC 2 0.0000
471 HEADACHE 23 0.0000
472 RESPIRATORY DISTRESS 1 0.0000
473 ANAPHYLACTIC REACTION 2 0.0000
474 FEELING COLD 1 0.0000
475 HYPERSOMNIA 1 0.0000
476 ABDOMINAL PAIN UPPER 7 0.0000
477 ACUTE MYOCARDIAL INFARCTION 1 0.0000
478 RESPIRATORY DISORDER 1 0.0000
479 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
480 EMOTIONAL DISORDER 1 0.0000
481 DRUG-INDUCED LIVER INJURY 1 0.0000
482 PARAESTHESIA 5 0.0000
483 HEAD INJURY 1 0.0000
484 METABOLIC ACIDOSIS 1 0.0000
485 LACTIC ACIDOSIS 1 0.0000
486 ATRIAL FIBRILLATION 3 0.0000
487 VISUAL ACUITY REDUCED 1 0.0000
488 LIP SWELLING 1 0.0000
489 SKIN DISORDER 1 0.0000
490 CEREBROVASCULAR ACCIDENT 5 0.0000
491 NEOPLASM PROGRESSION 1 0.0000
492 COUGH 8 0.0000
493 HYPERGLYCAEMIA 1 0.0000
494 RESTLESSNESS 1 0.0000
495 FATIGUE 21 0.0000
496 DYSARTHRIA 1 0.0000
497 MUSCULAR WEAKNESS 3 0.0000
498 COLITIS 1 0.0000
499 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
500 PALPITATIONS 3 0.0000
501 ABNORMAL BEHAVIOUR 1 0.0000
502 DISORIENTATION 1 0.0000
503 BLINDNESS 1 0.0000
504 CARDIAC ARREST 2 0.0000
505 RHABDOMYOLYSIS 1 0.0000
506 MYALGIA 4 0.0000
507 RECTAL HAEMORRHAGE 1 0.0000
508 DRY SKIN 3 0.0000
509 COLITIS ULCERATIVE 1 0.0000
510 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
511 THROAT IRRITATION 1 0.0000
512 PRODUCT QUALITY ISSUE 3 0.0000
513 CHEST PAIN 4 0.0000
514 COGNITIVE DISORDER 1 0.0000
515 ARRHYTHMIA 1 0.0000
516 OCULAR HYPERAEMIA 1 0.0000
517 COMA 1 0.0000
518 BLOOD GLUCOSE DECREASED 1 0.0000
519 PRURITUS 8 0.0000
520 AGGRESSION 1 0.0000
521 DEPRESSED MOOD 1 0.0000
522 DRUG EFFECT DECREASED 1 0.0000
523 OEDEMA 1 0.0000
524 MEDICATION ERROR 1 0.0000
525 OXYGEN SATURATION DECREASED 1 0.0000
526 URINARY TRACT INFECTION 3 0.0000
527 HERPES ZOSTER 1 0.0000
528 SURGERY 1 0.0000
529 VERTIGO 1 0.0000
530 DISCOMFORT 1 0.0000
531 NASOPHARYNGITIS 3 0.0000
532 AMNESIA 1 0.0000
533 RENAL FAILURE 2 0.0000
534 HEPATIC ENZYME INCREASED 1 0.0000
535 INJECTION SITE REACTION 1 0.0000
536 SKIN BURNING SENSATION 1 0.0000
537 MOBILITY DECREASED 1 0.0000
538 OVERDOSE 3 0.0000
539 RASH 6 0.0000
540 UNDERDOSE 1 0.0000
541 BRONCHITIS 1 0.0000
542 WEIGHT INCREASED 3 0.0000
543 BLOOD PRESSURE INCREASED 2 0.0000
544 DRUG INTERACTION 2 0.0000
545 CARDIAC FAILURE CONGESTIVE 1 0.0000
546 TREATMENT FAILURE 1 0.0000
547 DRUG ABUSE 1 0.0000
548 RENAL IMPAIRMENT 1 0.0000
549 MYOCARDIAL INFARCTION 2 0.0000
550 MALAISE 5 0.0000
551 WEIGHT DECREASED 3 0.0000
552 CONTUSION 1 0.0000
553 DYSPEPSIA 1 0.0000
554 HEART RATE INCREASED 1 0.0000
555 SYNCOPE 1 0.0000
556 ERYTHEMA 2 0.0000
557 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
558 INCORRECT DOSE ADMINISTERED 2 0.0000
559 SEIZURE 1 0.0000
560 DISEASE PROGRESSION 1 0.0000
561 JOINT SWELLING 1 0.0000
562 VISUAL IMPAIRMENT 1 0.0000
563 LOSS OF CONSCIOUSNESS 1 0.0000
564 VISION BLURRED 1 0.0000
565 HYPOAESTHESIA 1 0.0000
566 PERIPHERAL SWELLING 1 0.0000
567 URTICARIA 1 0.0000
568 TOXICITY TO VARIOUS AGENTS 1 0.0000
569 COVID-19 1 0.0000
570 PRODUCT USE ISSUE 1 0.0000
571 GAIT DISTURBANCE 1 0.0000
572 DECREASED APPETITE 1 0.0000
573 BACK PAIN 1 0.0000
574 ANXIETY 1 0.0000
575 PAIN IN EXTREMITY 1 0.0000
576 FALL 1 0.0000
577 ARTHRALGIA 1 0.0000